DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/xdr8vb/2012_global_chancr) has announced the addition of the "2012 Global Chancroid Diagnostics Market Outlook: Test Volumes, Sales Forecasts and, Supplier Shares by Country" report to their offering.
The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Chancroid tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Key Topics Covered:
CHANCROID DIAGNOSTICS MARKET: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares
I. Introduction
II. Worldwide Market and Technology Overview
III. France: Test Volume and Diagnostics Sales Forecast by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Chemicon
- Daiichi
- DiaSorin
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
For more information visit http://www.researchandmarkets.com/research/xdr8vb/2012_global_chancr